Optiscan Imaging: No more biopsies? – a serious revolution in medical science
Optiscan Imaging Managing Director Camile Farah on 2GB Bulls N' Bears Report
Listen to ASX-listed Optiscan Imaging Managing Director Dr Camile Farah talk to Matt Birney on the Bulls N’ Bears Report about Optiscan’s game changing imaging tech that can determine a cancerous cell without a painful biopsy.
TO LISTEN TO THE OPTISCAN IMAGING AUDIO INTERVIEW - CLICK BELOW
Optiscan Imaging is an ASX-listed medical technology company that has developed a range of super-high-powered imaging devices that can be used in a variety of clinical settings including cancer diagnosis and treatment. Just this week the company unveiled its latest InVue imaging device which has the potential to open up a whole new market for the company in the precision surgery field.